Management of glioblastoma: comparison of clinical practices and cost-effectiveness in two cohorts of patients (2008 versus 2004) diagnosed in a French university hospital-Reference-Cited by-同舟云学术

Management of glioblastoma: comparison of clinical practices and cost-effectiveness in two cohorts of patients (2008 versus 2004) diagnosed in a French university hospital

Published:2014-08-28 Issue:6 Volume:39 Page:642-648
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Diebold G.¹,Ducray F.²³,Henaine A.-M.⁴,Frappaz D.⁵,Guyotat J.⁶,Cartalat-Carel S.²,Breant V.¹,Fouquet A.¹,Aulagner G.¹⁴,Honnorat J.²³⁷,Armoiry X.⁴⁸

Affiliation:

1. Pharmacy Department; Hospices Civils de Lyon; Groupement Hospitalier Est; Lyon France

2. Neuro-Oncology Departement; Hospices Civils de Lyon; Hôpital Neurologique Pierre Wertheimer; Lyon France

3. University Claude Bernard Lyon 1; Université de Lyon; Lyon France

4. UMR CNRS 5510 MATEIS; Lyon France

5. Department of Pediatric and Adult Neuro-Oncology; Centre Léon Bérard; Lyon France

6. Neurosurgery Department; Hospices Civils de Lyon; Hôpital Neurologique Pierre Wertheimer; Lyon France

7. UMR Inserm U1028/CNRS 5292; Lyon's Neuroscience Research Center; Lyon France

8. Délégation à la Recherche Clinique et à l'Innovation; Cellule Innovation; Hospices Civils de Lyon; Lyon France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jcpt.12199/fullpdf

Reference32 articles.

1. French brain tumor database: general results on 40,000 cases, main current applications and future prospects;Zouaoui;Neurochirurgie,2012

2. Malignant gliomas in adults;Wen;N Engl J Med,2008

3. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma;Stupp;N Engl J Med,2005

4. Bevacizumab plus irinotecan in recurrent glioblastoma multiforme;Vredenburgh;J Clin Oncol Off J Am Soc Clin Oncol,2007

5. FDA drug approval summary: bevacizumab (Avastin) as treatment of recurrent glioblastoma multiforme;Cohen;Oncologist,2009

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Racial and social-economic inequalities in systemic chemotherapy use among adult glioblastoma patients following surgery and radiotherapy;Scientific Reports;2024-08-17

2. Economic Evaluations Informed Exclusively by Real World Data: A Systematic Review;International Journal of Environmental Research and Public Health;2020-02-12

3. Impact of treatment decision algorithms on treatment costs in recurrent glioblastoma: a health economic study;Swiss Medical Weekly;2019-12-02

4. Survival effects of a strategy favoring second-line multimodal treatment compared to supportive care in glioblastoma patients at first progression;Journal of Neurosurgery;2019-10

5. Quality-adjusted life years in glioma patients: a systematic review on currently available data and the lack of evidence-based utilities;Journal of Neuro-Oncology;2019-06-12